Cover Image
市場調查報告書

Pherin Pharmaceuticals, Inc. - 產品平台檢討

Pherin Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 192774
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Pherin Pharmaceuticals, Inc. - 產品平台檢討 Pherin Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 25 Pages
簡介

Pherin Pharmaceuticals, Inc.是開發、製造行動·精神神經·神經內分泌障礙治療藥的製藥公司。該公司同時也在進行針對社會不安障礙,經前症候群,更年期的熱潮紅,憂鬱症等疾病的治療藥開發計劃。並研究開發視丘下部及腦邊緣領域的調整分子。

本報告提供Pherin Pharmaceuticals, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Pherin Pharmaceuticals, Inc.的基本資料

  • Pherin Pharmaceuticals, Inc.概要
  • 主要資訊
  • 企業資料

Pherin Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Pherin Pharmaceuticals, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Pherin Pharmaceuticals, Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Pherin Pharmaceuticals, Inc.:藥物簡介

  • PH-94B
  • PH-10A
  • PH-80PMD
  • Salubrin-HF
  • PH-15

Pherin Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Pherin Pharmaceuticals, Inc.:最近的開發平台趨勢

Pherin Pharmaceuticals, Inc.:暫停中的計劃

Pherin Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07539CDB

Summary

Global Markets Direct's, 'Pherin Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Pherin Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pherin Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Pherin Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Pherin Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Pherin Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Pherin Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Pherin Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Pherin Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Pherin Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pherin Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Pherin Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Pherin Pharmaceuticals, Inc. Snapshot
    • Pherin Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Pherin Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Pherin Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Pherin Pharmaceuticals, Inc. - Pipeline Products Glance
    • Pherin Pharmaceuticals, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Pherin Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Pherin Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Pherin Pharmaceuticals, Inc. - Drug Profiles
    • PH-94B
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PH-10
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PH-80PMD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Salubrin-HF
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PH-15
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Pherin Pharmaceuticals, Inc. - Pipeline Analysis
    • Pherin Pharmaceuticals, Inc. - Pipeline Products by Target
    • Pherin Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Pherin Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Pherin Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Pherin Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Pherin Pharmaceuticals, Inc. - Dormant Projects
  • Pherin Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Pherin Pharmaceuticals, Inc., Key Information
  • Pherin Pharmaceuticals, Inc., Key Facts
  • Pherin Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Pherin Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Pherin Pharmaceuticals, Inc. - Phase III, 2015
  • Pherin Pharmaceuticals, Inc. - Phase II, 2015
  • Pherin Pharmaceuticals, Inc. - Preclinical, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Pherin Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Pherin Pharmaceuticals, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Pherin Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Pherin Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Pherin Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top